Aya Sugimoto

A phase II study of cediranib (AZD2171) in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: Final results of a PMH, Chicago and California consortia trial

Hal W. Hirte, Liat Vidal, Gini F. Fleming et al. · Journal of Clinical Oncology · 2008 · 83 citations

Final Results, Tumoral Pathology, Gastrointestinal Oncology +14

Glucosamine Suppresses Osteoclast Differentiation through the Modulation of Glycosylation Including <i>O</i>-GlcNAcylation

Tomoharu Takeuchi, Aya Sugimoto, Nao Imazato et al. · Biological and Pharmaceutical Bulletin · 2017 · 37 citations · Full text

Signal Transduction, Biochemistry, Cell Signaling +14

Evaluation of DNA and RNA quality from archival formalin‐fixed paraffin‐embedded tissue for next‐generation sequencing – Retrospective study in Japanese single institution

Tomomi Fujii, Tomoko Uchiyama, Minami Matsuoka et al. · Pathology International · 2020 · 34 citations

Nivolumab Induces Sustained Liver Injury in a Patient with Malignant Melanoma

Tokuhiro Matsubara, Tsutomu Nishida, Yu Higaki et al. · Internal Medicine · 2018 · 33 citations · Full text

Classification and clinical features of adverse drug reactions in patients with ulcerative colitis treated with 5‐aminosalicylate acid: a single-center, observational study

Yuri Tsujii, Tsutomu Nishida, Naoto Osugi et al. · Scandinavian Journal of Gastroenterology · 2021 · 33 citations